A72200

• EUDAMED Basic UDI-DI 0763000B000020878 registered 23 Jul 2026 Active· +1 more in the status table
• FDA PMA P840001 decided 30 Nov 1984 Active
• FDA GUDID UDI-DI 00763000287290 listed 19 Jun 2021 Listed

• • Ongoing Z-0372-2025 FDA Class II ·initiated 18 Sep 2024

  The Wireless Rechargers in the kits may be unable to enter a recharging session upon first use.

• • Ongoing Z-1691-2024 FDA Class II ·initiated 28 Mar 2024

  inability to reprogram one device

• • Ongoing Z-0780-2024 FDA Class II ·initiated 19 Dec 2023

  Medtronic has discovered an instance in which the Intellis A710 Clinician Programmer Application (CP App) could no longer establish a session with the Implantable Neurostimulator (INS) which resulted in the inability for the clinician to adjust stimulation parameters. In the event of this issue, the patient may receive inadequate or excessive therapy and experience non-optimal pain relief.

• • Ongoing Z-2159-2021 FDA Class II ·initiated 9 Jul 2021

  Specific PINs of the Vectris SureScan MRI lead kits contain the incorrect lead electrode spacing information printed on the shelf box and the sterile pack labeling.

• • Terminated Z-1926-2016 FDA Class II ·initiated 3 May 2016

  Loss of therapy during recharging of device. Reportedly, a charging session was terminated prior to obtaining recharge threshold voltage of 3.615, which triggered rapid battery depletion state. As a result, the device depleted to 1.925 volts in one to two days rather than the typical 30 days. Insufficient coupling between recharger and device during recharge session was found to be key factor.

• • Terminated Z-1147-2015 FDA Class II ·initiated 9 Jan 2015

  Current labeling indicates that cycling improves device longevity in every programming scenario. However, enabling cycling at certain parameter settings may decrease the device battery longevity. With cycling enabled, longevity estimate displayed on the Model 8840Programmer may be inaccurate.

• • Terminated Z-1524-2014 FDA Class II ·initiated 27 Feb 2014

  Medtronic neurostimulators (used with pain and deep brain stimulation therapy) have a cycling feature that, when enabled, allows stimulation output to be toggled on and off based on the programmed settings. The use of this feature is determined by the physician and set using the clinician programmer. Current labeling indicates the use of cycling improves device longevity and recharge interval

• • Terminated Z-0278-2014 FDA Class II ·initiated 30 Sep 2013

  Medtronic notified customers regarding Loss of Stimulation of specific Implantable Neuro-Stimulators under the following specific conditions: Switching between groups with Multiple programs or creating program groups. Therapy can be restored with the Physician Recharge mode (RPM) of the Implantable Neurostimulator Recharger (INSR).

• • Terminated Z-1536-06 FDA Unclassified (pre-2012) ·initiated 2 Aug 2006

  Model 3777 Standard Octad Lead (Lot V009545) and Model 3778 Compact Octad Lead (Lot V009546) were mispackaged. The result of this error is that lead kits labeled 3777 lot V009545 may contain a 3778 compact-spaced lead, while those labeled 3778 lot V009546 may contain a 3777 standard-spaced lead. The result of this error is an overall increase or decrease of 14 mm in the electrode coverage.

1. 9 Jan 2015 Recall initiated FDA recalls Z-1147-2015
2. 3 May 2016 Recall initiated FDA recalls Z-1926-2016
3. 19 Jun 2021 Listed FDA GUDID 00763000287290
4. 9 Jul 2021 Recall initiated FDA recalls Z-2159-2021
5. 19 Dec 2023 Recall initiated FDA recalls Z-0780-2024
6. 28 Mar 2024 Recall initiated FDA recalls Z-1691-2024
7. 18 Sep 2024 Recall initiated FDA recalls Z-0372-2025
8. 10 Jul 2026 Certificate issued EUDAMED G70 039709 1366
9. 23 Jul 2026 Registered EUDAMED 0763000B000020878
10. 7 Sep 2031 Certificate expires EUDAMED G70 039709 1366

4 earlier events are in the sections above.

Generic name

Multiple active implantable device programmer

Device name

MyStim PC Therapy Application

Model / reference

A72200

Primary DI / UDI-DI

00763000287290

Basic UDI-DI

0763000B000020878

PMA number

P840001 ↗

FDA product code

LGW, QRB

EMDN code

J020782 Neurostimulators programmers - software accessories

GMDN term

Multiple active implantable device programmer

Device class

Class III

Special device type

Software

EU registration type

Standard device

EU market of registration

Netherlands

GUDID distribution status

In Commercial Distribution

Category: Multiple active implantable device programmer

Other devices filed under NEUROSTIMULATORS PROGRAMMERS AND ACCESSORIES.

• VNS Therapy® Programming Wand Model 2000 by LivaNova USA, Inc.
• Evoke® RECAP® Viewer 1045 by Saluda Medical Pty Ltd
• Evoke® Clarity™ Programming Application 1044 by Saluda Medical Pty Ltd
• Barostim™ Programmer System 100067-201 by Cvrx, Inc.
• NCP® Programming Wand Model 201 by LivaNova USA, Inc.
• Training Software For Visual Function Therapy SJ-MRS2016 by Guangzhou Shijing Medical Software Co., Ltd.
• Freelink™ SC-5240 by Boston Scientific Neuromodulation

• BB11A61R10

  Class II

  FDA 510(k) K171979 Active Cleared 27 Oct 2017 GUDID on market

• CapSureFix™ Novus

  Class III

  CE/MDR

• Rf Marinr™

  Class III

  CE/MDD

• Achieve™

  Class III

  CE/MDD

See all devices from Medtronic, Inc. →